Danahervs.Waters Corporation
DHR vs WAT · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Danaher is about 3.7× larger than Waters Corporation by market cap; Danaher trades at the lower P/E (38.1 vs 83.5); year to date, Waters Corporation leads (−0.9% vs −13.0%).
Side by side
| DHR | WAT | |
|---|---|---|
| Market cap | $141B | $37.5B |
| Price | $199.05 | $376.43 |
| Today | +1.6% | −0.2% |
| Return YTD | −13.0% | −0.9% |
| Return 1Y | −3.1% | +6.6% |
| P/E | 38.1 | 83.5 |
| P/S | 5.7 | 9.9 |
| P/B | 2.7 | 2.5 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
DanaherDHR
American group focused on life science and diagnostics — bioprocessing (Cytiva), molecular diagnostics and laboratory solutions.
Full DHR profile →Waters CorporationWAT
Analytical instruments (chromatography and mass spectrometry) for pharma and labs.
Full WAT profile →More comparisons in Life science tools
See where DHR and WAT sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →